Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
NCT07562542 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-05-01
Summary
This observational study aims to evaluate the diagnostic value and clinical utility of detecting the KIT-D816V mutation in the peripheral blood of adult patients with systemic mastocytosis (SM), using droplet digital PCR (ddPCR). Currently, the diagnosis of SM relies heavily on invasive bone marrow biopsies. This study will determine whether highly sensitive ddPCR testing of peripheral blood could provide a reliable, minimally invasive alternative for detecting the KIT-D816V mutation, which is a key driver of the disease and a major diagnostic criterion. The results could optimize the diagnostic process and continuous monitoring of adult SM patients.
Conditions
- Systemic Mastocytosis
- KIT-D816V Mutation
Sponsors & Collaborators
-
The First Affiliated Hospital of Soochow University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-19
- Primary Completion
- 2028-05-19
- Completion
- 2028-07-31
Countries
- China
Study Locations
More Related Trials
-
Central China Rosai-Dorfman Disease Registry
NCT05284942 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Analysis of Juvenile Dermatomyositis Patients
NCT05509140 ·Status: COMPLETED
-
Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission
NCT01265082 ·Status: UNKNOWN
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis
NCT04244916 ·Status: TERMINATED
-
Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD
NCT05781516 ·Status: UNKNOWN ·Phase: NA
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
NCT00001764 ·Status: COMPLETED ·Phase: PHASE1
-
Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis
NCT03316651 ·Status: UNKNOWN ·Phase: PHASE2
-
MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.
NCT07000292 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome
NCT05843968 ·Status: RECRUITING ·Phase: PHASE2
-
Mycophenolate for Pulmonary Sarcoidosis
NCT00262132 ·Status: TERMINATED ·Phase: PHASE3
-
MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis
NCT00301652 ·Status: COMPLETED ·Phase: NA
-
Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
NCT01983657 ·Status: UNKNOWN ·Phase: PHASE2
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
MoMa Signature During Granulomatosis
NCT05916638 ·Status: RECRUITING
-
Assessment of Macrophage Activation syndromE in STill's Disease in Italy
NCT06992505 ·Status: COMPLETED
-
Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
NCT04509219 ·Status: UNKNOWN ·Phase: PHASE1
-
Interleukin-8 Level in Packed Red Blood Cells
NCT06530160 ·Status: NOT_YET_RECRUITING
-
A Prospective & Retrospective Study on Ectopic Lymphoid-like Structures in Chronic Skins of Autoimmune Bullous Diseases
NCT04509570 ·Status: COMPLETED ·Phase: NA
-
Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)
NCT02243228 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Renal Sarcoidosis by Methylprednisolone Bolus
NCT01652417 ·Status: TERMINATED ·Phase: NA
-
Mast Cell Connect: A Registry for Patients With Mastocytosis
NCT02620254 ·Status: COMPLETED